To elucidate the role of Pirh2 in p53-negative cancer cells we decided to assess the effect of Pirh2 expression on classical characteristics of tumorigenecity: proliferation, invasion potential, and resistance to anti-cancer drugs. This evidence concerns the gene TP53 and cancer.